K. Shoji et al., INHIBITORY EFFECTS OF A BISPHOSPHONATE (RISEDRONATE) ON EXPERIMENTAL PERIODONTITIS IN RATS, Journal of Periodontal Research, 30(4), 1995, pp. 277-284
The present study was designed to examine whether systemic administrat
ion of a bisphosphonate, risedronate, could prevent alveolar bone reso
rption in rats with experimental periodontitis. On Day 1, an elastic r
ing was placed around the neck of the right mandibular Ist molar to in
duce inflammatory periodontitis. The animals were given daily injectio
ns of either 0.9% NaCl (control group), or 0.8, 1.6 or 3.2 mu moles/kg
(s.c.) of risedronate (experimental groups) from Days 1 to 7, and wer
e killed on Day 8. Histological examinations and determination of bone
mineral density in the interdental area between the 1st and 2nd molar
s with an image analyzer revealed that the presence of the elastic rin
g induced a loss of attachment and bone resorption in the control grou
p. Vigorous bone resorption, with appearance of a large number of oste
oclasts, was observed in the interdental and bifurcation areas. In the
experimental groups, however, the resorption of alveolar bone and the
loss of bone mineral content in these areas were prevented in a dose-
dependent fashion, especially at doses of 1.6 and 3.2 mu moles/kg. Man
y osteoclasts were detached from the surface of the alveolar bone and
had degenerated appearances, such as rounded shapes, loss of polarity
and pyknosis. These results suggest that administration of risedronate
is effective in preventing bone resorption in periodontitis.